在过去的20年中，乳腺癌幸存者的患病率一直在稳步增加。目前，由于早期检测和多模式治疗策略的突破性创新，90%以上的早期乳腺癌患者在诊断后5年预计存活。除了临床结果方面的进展之外，乳腺癌幸存者可能会面临一些特定的挑战，并呈现出独特的需求。经过乳腺癌诊断和治疗后的幸存者群体可能会受到长期而严重的治疗相关副作用的影响，包括身体问题、心理困扰、年轻女性的生育问题以及社会和职业重返的困难，这些副作用加起来可能会增加患者癌症复发和第二原发性恶性肿瘤的风险。除了癌症特异性后遗症之外，幸存者仍然面临着一般的健康需求，包括处理慢性现有或继发的病症。幸存者护理应该实施高质量的、基于证据的策略，全面地及时筛查、识别和解决幸存者的需求，最小化严重治疗后遗症、现有的共病、不健康的生活方式和癌症复发的风险对生活质量的影响。本叙述性综述侧重于幸存者护理的核心领域，并讨论关键领域包括选择的长期副作用、复发和第二次癌症的监测、促进幸存者的福祉以及特定幸存者的需求的现状和未来研究方向。© 2023 作者。

Prevalence of survivors of breast cancer has been steadily increasing in the last 20 years. Currently, more than 90% of women diagnosed with early-stage breast cancer are expected to be alive at 5 years from diagnosis thanks to early detection and breakthrough innovations in multimodal treatment strategies. Alongside this advancement in clinical outcomes, survivors of breast cancer might experience several specific challenges and present with unique needs. Survivorship trajectories after diagnosis and treatment of breast cancer can be significantly impacted by long-lasting and severe treatment-related side effects, including physical problems, psychological distress, fertility issues in young women, and impaired social and work reintegration, which add up to patients' individual risk of cancer recurrence and second primary malignancies. Alongside cancer-specific sequelae, survivors still present with general health needs, including management of chronic preexisting or ensuing conditions. Survivorship care should implement high-quality, evidence-based strategies to promptly screen, identify, and address survivors' needs in a comprehensive way and minimize the impact of severe treatment sequelae, preexisting comorbidities, unhealthy lifestyles, and risk of recurrence on quality of life. This narrative review focuses on core areas of survivorship care and discuss the state of the art and future research perspectives in key domains including selected long-term side effects, surveillance for recurrences and second cancers, well-being promotion, and specific survivors' needs.© 2023. The Author(s).